Skip to main content

Table 1 Key indicators for disease prevalence and treatment for pneumonia and diarrhoea

From: Impact of an integrated community case management programme on uptake of appropriate diarrhoea and pneumonia treatments in Uganda: A propensity score matching and equity analysis study

Disease/treatment

2009

 

2012

 

Increase year on year percentage points

p-value

 

N (1178)

%

N (1476)

%

  

Two week prevalence of ‘fast-breathing’ pneumonia

263

22.3 %

453

30.7 %

8.4

0.000a

Two week prevalence of diarrhoea

168

14.6 %

229

15.6 %

1.0

0.470

‘Fast-breathing’ pneumonia treated with appropriate antibiotics

147

55.9 %

301

66.4 %

10.5

0.000a

Diarrhoea treated with ORS

58

34.5 %

117

51.1 %

16.6

0.001a

Diarrhoea treated with ORS plus zinc

5

3.0 %

27

11.8 %

8.8

0.001a

Treatment

First source of care 2012

p-value

  

iCCM n (%)

Other n (%)

 

‘Fast-breathing’ pneumonia treated with appropriate antibiotics (N = 453)

 

184 (85.6)

117 (49.2)

0.000a

Diarrhoea treated with ORS (N = 229)

 

65 (80.2)

52 (35.14)

0.000a

Diarrhoea treated with ORS plus zinc (N = 229)

 

22 (14.9)

5 (6.2)

0.056

  1. aSignificant at 95 % level of significant